These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22853981)

  • 21. Radiotherapy patterns of care study in lung carcinoma.
    Movsas B; Moughan J; Komaki R; Choy H; Byhardt R; Langer C; Goldberg M; Graham M; Ettinger D; Johnstone D; Abrams R; Munden R; Starkschall G; Owen J
    J Clin Oncol; 2003 Dec; 21(24):4553-9. PubMed ID: 14597743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiation therapy for lung cancer].
    Shibuya K; Hiraoka M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):544-9. PubMed ID: 17431339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer.
    Holloway CL; Robinson D; Murray B; Amanie J; Butts C; Smylie M; Chu K; McEwan AJ; Halperin R; Roa WH
    Radiother Oncol; 2004 Dec; 73(3):285-7. PubMed ID: 15588872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.
    Verbakel WF; van Reij E; Ladenius-Lischer I; Cuijpers JP; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e297-303. PubMed ID: 22579380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.
    Lee CB; Stinchcombe TE; Rosenman JG; Socinski MA
    Clin Lung Cancer; 2006 Nov; 8(3):195-202. PubMed ID: 17239295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases.
    Fritz P; Kraus HJ; Mühlnickel W; Hammer U; Dölken W; Engel-Riedel W; Chemaissani A; Stoelben E
    Radiat Oncol; 2006 Aug; 1():30. PubMed ID: 16919172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
    Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
    Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited-disease small-cell lung cancer.
    Zimmermann FB; Bamberg M; Molls M; Jeremic B
    Semin Surg Oncol; 2003; 21(3):156-63. PubMed ID: 14508848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.
    Rusthoven KE; Hammerman SF; Kavanagh BD; Birtwhistle MJ; Stares M; Camidge DR
    Acta Oncol; 2009; 48(4):578-83. PubMed ID: 19373699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of radiation therapy in non-small cell lung cancer.
    Mohiuddin MM; Choi NC
    Semin Respir Crit Care Med; 2005 Jun; 26(3):278-88. PubMed ID: 16052429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer.
    Shi W; Liu C; Lu B; Yeung A; Newlin HE; Amdur RJ; Olivier KR
    Am J Clin Oncol; 2010 Apr; 33(2):153-6. PubMed ID: 19806038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.
    Hoffmann AL; Troost EG; Huizenga H; Kaanders JH; Bussink J
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1596-602. PubMed ID: 22245206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.